核酶在基因治疗中的研究进展(3)
作者：佚名； 更新时间：2014-12-13
3］Birikh KR,Nason BK.Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences［J］.Eur J Biochem,1997，245(2):1-8.
［14］Aoki Y,Scott R ,Landy U,et al.The virtues of self-binding:high sequence specificity for RNA cleavage by self-processed hammerhead ribozymes［J］.Virology,1998，283(4):571-578.
［15］Leontis NB,Douhue D,Spetize K,et al.Hammerhead ribozyme mechanism:a ribonucleotide 5’ to the substrate cleavage site is not essential［J］.J Mol Biol,1998，283(5):571-578.
［16］Langon T,Frand P,Fans H, et al.Ribozyme-catalyzed tRNA aminoacylation［J］.Res Virol,1998，149(5)：171-178.
［17］Daley GQ,Testa H,Chank J,et al.Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA［J］.Science,1990，247(8):824-829.
［18］Nason BK,Nukidy P,Ling Y,et al.ALA molecular description of the evolution of resistance［J］.Oncogene,1998，17(5):1759-1766.
［19］Du Z,Greman,JY, Denty,A,et al.Exiting an RNA world［J］.Human Gene Therapy,1998，9(4)：1551-1558.
［14］Aoki Y,Scott R ,Landy U,et al.The virtues of self-binding:high sequence specificity for RNA cleavage by self-processed hammerhead ribozymes［J］.Virology,1998，283(4):571-578.
［15］Leontis NB,Douhue D,Spetize K,et al.Hammerhead ribozyme mechanism:a ribonucleotide 5’ to the substrate cleavage site is not essential［J］.J Mol Biol,1998，283(5):571-578.
［16］Langon T,Frand P,Fans H, et al.Ribozyme-catalyzed tRNA aminoacylation［J］.Res Virol,1998，149(5)：171-178.
［17］Daley GQ,Testa H,Chank J,et al.Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA［J］.Science,1990，247(8):824-829.
［18］Nason BK,Nukidy P,Ling Y,et al.ALA molecular description of the evolution of resistance［J］.Oncogene,1998，17(5):1759-1766.
［19］Du Z,Greman,JY, Denty,A,et al.Exiting an RNA world［J］.Human Gene Therapy,1998，9(4)：1551-1558.
